SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-000911
Filing Date
2018-01-25
Accepted
2018-01-25 16:05:55
Documents
7
Period of Report
2018-01-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20180125.htm 8-K 31991
2 EX-99.1 life-ex991_69.htm EX-99.1 17398
3 GRAPHIC g201801251543323568823.jpg GRAPHIC 94101
4 GRAPHIC g201801251543323018821.jpg GRAPHIC 79787
5 GRAPHIC g201801251543322648820.jpg GRAPHIC 95805
6 GRAPHIC g201801251543322628820.jpg GRAPHIC 1349
7 GRAPHIC g201801251543323268822.jpg GRAPHIC 89675
  Complete submission text file 0001564590-18-000911.txt   548061
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 18548336
SIC: 2836 Biological Products, (No Diagnostic Substances)